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The purpose of this dissertation research was to investigate whether there is an 
association between exposure to low to moderate levels of arsenic in drinking water in 
community water systems (CWSs) and small for gestational age birth (SGA), pregnancy-related 
hypertension, and/or stillbirth. The study included over 633,000 live births and stillbirths to 
Utah residents during 1989 to 2006 where the maternal addresses recorded on birth and fetal 
death certificates were within the boundaries of a CWS. Over 97% of the maternal addresses in 
each county were geocoded and then spatially linked to georeferenced data layers of 476 CWS 
service areas statewide and to elevation data. Water quality data collected for regulatory 
purposes were used to estimate annual average arsenic levels for each CWS; these values were 
assigned to the births and stillbirths based on the first trimester of the year of pregnancy and 
the CWS providing water to the maternal residence. Arsenic levels were less than 2.5 
micrograms per liter (µg/L) for the majority of residences (73.8%); arsenic levels were greater 
than 10 µg/L at only 3.7% of the residences. There was a small but statistically significant 
association between arsenic concentration and SGA. Using <2.5 µg/L as the reference, the 
adjusted odds ratio (aOR) for SGA was 1.04, (95% confidence interval (CI) 1.00, 1.07) when 
arsenic levels were 5.1 to 9.9 µg/L (p-value 0.03), and aOR 1.07 (CI 1.03, 1.12) when levels 
were 10 µg/L or greater (p-value 0.002). At arsenic levels from 2.5 to 5 µg/L, there was a 
small, but not statistically significant (p-value 0.40), increase in SGA (aOR 1.01, CI 0.98, 1.04). 
Arsenic was not found to be associated with pregnancy-related hypertension, nor was there an 
association between low to moderate levels of arsenic in drinking water and stillbirth. An 
additional finding was that, compared with births at elevations less than 3,000 feet(ft), the 
frequency of SGA increased with every 1,000 ft increase in elevation to an aOR of 1.91  
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At high levels of chronic exposure, arsenic has been associated with a number of 
adverse reproductive outcomes, including preterm birth, lower birth weight, infant mortality, 
spontaneous abortion, and stillbirth (1-19). These associations, however, have not been 
demonstrated conclusively (20-21) due to study methodology, small sample sizes, and 
confounding by other occupational exposures.  
Arsenic is a naturally occurring metal that enters drinking water sources through 
erosion and dissolution of rocks and minerals (22). Humans are exposed to arsenic through 
intake of food, water, and air (23). Exposure to arsenic in air is primarily through 
anthropogenic sources such as metal smelting, roasting of gold ores, coal or oil combustion, 
municipal waste incineration, and agricultural processes (23, 24). Natural sources of airborne 
arsenic exposure include dust from naturally occurring arsenic in soil, sea salt spray, volcanoes, 
fumaroles, and forest fires (23). Food is usually the major source of arsenic exposure; however, 
most adverse effects are attributed to exposure to arsenic in drinking water. The main reason 
is that in most foods arsenic is in the organic form of arsenic, while arsenic in drinking water is 
the more toxic inorganic form of arsenic, and is at relatively higher concentrations (25). 
Arsenic intake for a typical adult in the United States (US) is approximately 5 µg/day; however, 
intake in areas with high levels of arsenic in drinking water can be much higher (10-100  
µg/day) (23). Preparing foods in arsenic-containing water can increase the arsenic content by 
10-50% for most foods, and by 200-250% for foods that absorb cooking water such as beans and 





Groundwater arsenic levels vary across the US, with higher levels in many areas of the 
western states. In Utah, weathering of volcanic rocks and erosion of slag and soil from past 
mining activities are the major sources of arsenic in groundwater (27, 28). Arsenic levels in 
drinking water vary greatly throughout Utah, ranging from below the limit of detection to over 
400 micrograms per liter (µg/l) in some private wells (27, 29).  
Arsenic levels in public water systems have been regulated in the US since 1942, when 
the US Public Health Service set the standard at 50 micrograms per liter (µg/L). The US 
Environmental Protection Agency (EPA) adopted this standard in 1974 and set the initial 
Maximum Contaminant Level (MCL) at 50 µg/L (30). In 1993, the World Health Organization 
adopted an arsenic standard of 10 µg/L for drinking water (25). After decades of debate, the 
EPA lowered the MCL to 10 µg/L, effective January 2006 (31). Due to the expense of modifying 
infrastructure to reduce arsenic levels, the regulations permitted CWSs to apply for multi-year 
exemptions, allowing them more time to develop new water sources and modify water 
treatment equipment to reduce arsenic levels. Over 30 CWS in Utah were granted these 
exemptions (30). National drinking water standards do not apply to private wells, and no water 
monitoring or treatment is required for arsenic (32). The Utah Department of Natural 
Resources (UDNR) estimates that only 1.5% of residential water in Utah is supplied by private 
domestic wells (33). If risks for adverse reproductive outcomes are found to be elevated in 
those exposed to moderately elevated levels of arsenic (or other regulated contaminants) in 
drinking water, advisories may be indicated for alternative water sources for pregnant women 
whose drinking water sources are in water districts that do not yet meet EPA standards, as well 
as for testing of arsenic levels in private wells, particularly in residences of women of 
childbearing age. 
Arsenic was one of the first chemicals recognized as a human carcinogen. In 1879, high 
rates of lung cancer in miners in Saxony was attributed in part to arsenic (34). A few years 
later, skin cancers were reported in patients treated with medicine containing arsenic. Chronic 
exposure to arsenic has also been associated with increased incidence of cancers of the 





diabetes (4, 23, 31, 34-38). The largest known population impacted by arsenic contamination 
of groundwater is in Bangladesh, where the UNICEF programs in the 1970s developed wells and 
encouraged the use of groundwater instead of surface water for drinking (10, 39). While deaths 
from waterborne pathogens were significantly reduced through these efforts (40),arsenic-
related health risks increased for the 35-77 million people now consuming water with very high 
levels of arsenic and other metals (39, 40).   
Most studies of the effects of arsenic exposure have been conducted in countries such 
as Bangladesh, Chile, Taiwan, and India where there were very high levels of arsenic (>300 
µg/L) in drinking water. Others studies were based on occupational exposures via air. There 
have been only a few studies of the health effects from chronic exposure to moderate levels of 
arsenic in drinking water (i.e., less than 50 µg/L), particularly in US populations. A cohort 
mortality study in Millard County, Utah, where arsenic levels ranged from 14-166 µg/L, found 
elevated levels of hypertensive heart disease and kidney disease (27). A study in Michigan, 
where the mean arsenic level in drinking water was 11 µg/L, provided additional evidence that  
serious health effects may result from exposure to lower levels of arsenic (41). These health 
effects included elevated mortality rates for circulatory system disease, cerebrovascular 
disease, diabetes mellitus, and kidney disease.  
Arsenic readily crosses the placental barrier (23, 42), and several  studies have found 
an increased incidence of reproductive and fetal developmental effects (genotoxic, mutagenic, 
and teratogenic) in a number of animal species (23, 31, 35, 43, 44). Epidemiologic studies have 
been inconclusive, and there are considerable knowledge gaps about the critical windows of 
exposure in humans (45). Additional studies with larger sample sizes have been recommended 
by the Agency for Toxic Substances and Diseases Registry to determine whether low to 
moderate levels of arsenic exposure contribute to adverse reproductive outcomes (23).  
There are no well-defined biological mechanisms to explain the adverse effects of 
arsenic exposure on reproductive outcomes; however, several modes of effect have been 
suggested (46). Vascular endothelial cells are suspected to be primary targets of arsenic 





and peripheral vascular disease, cerebrovascular disease, and carotid atherosclerosis (47-49). 
Since arsenic has been associated with these vascular effects, it is possible that arsenic may 
lead to some type of placental abnormality or decreased blood flow affecting fetal growth  
(15). Other theories include oxidative stress, interference with hormones, especially 
glucocorticoids and estrogen, or that increased methylation of arsenic during pregnancy may 
affect the fetus (42).   
Three health outcomes were selected for this study: small for gestational age, 
pregnancy-related hypertension, and stillbirth. These were chosen because: a) they 
demonstrated strong associations with arsenic exposure in previous studies, b) they can be 
identified through use of vital records, and/or c) the relationship between the outcome and 





Small for Gestational Age (SGA) 
 SGA is defined as an infant whose weight is less than the 10th percentile for  
gestational age. SGA is used a proxy for intrauterine growth restriction (IUGR) and its diagnosis 
requires knowledge of both birth weight and gestational age (50). Severely growth-restricted 
fetuses are at increased risk for stillbirth and neonatal death (50, 51). SGA has been associated 
with placental insufficiency (52), which is an hypothesized mechanism by which arsenic might 
adversely impact fetal growth.  
 
 
Pregnancy-Related Hypertension (PRH) 
 
PRH includes a group of life-threatening multisystem disorders, including eclampsia  
and preeclampsia, that generally occur after 20 weeks of pregnancy and include hypertension 
and proteinuria (53, 54). PRH is associated with preterm birth, perinatal morbidity and 
mortality, abruptio placenta, and IUGR (54, 55). There are very few studies on the association 
of arsenic exposure with hypertension (56-59) or with PRH (14). A study of hypertension in 





pressure with increasing exposure levels of arsenic (59); however, the study did not assess 
whether the women had pregnancy-related hypertension or preeclampsia during their 
pregnancies. A study in Bulgaria found that preeclampsia was significantly more common in 
pregnant women living near a smelter (exposed to arsenic in air and soil) (14). The incidence  
of PRH reported on Utah birth certificates in 2000-2002 was 55.7 per 1,000 births, while the 





Stillbirth is generally defined as fetal death after 20 weeks gestation (61). In Utah, 
fetal death certificates are required for fetal deaths at 20 or more weeks of gestation. For this 
study, “stillbirth” is defined as 1) pregnancy loss at 20 weeks gestation or later in Utah  
recorded on a fetal death certificate, and 2) pregnancy loss where a birth certificate was 
issued but the 1-minute and 5-minute Apgar scores were both zero. The incidence of stillbirth 
in Utah is approximately 4.9 per 1,000 live births (51). Stillbirth, as well as spontaneous 
abortion and neonatal mortality, have been associated with arsenic exposure in several studies 





 The specific aims of this study were to: 1) develop estimates of drinking water arsenic 
concentrations over time for Utah residents (age 18 and older) who delivered a live birth or  
had a stillbirth in Utah between January 1, 1989, and December 31, 2006, and whose residence 
was inside the boundaries of a CWS in Utah, and 2) examine the relationship between these 
exposures and three adverse reproductive outcomes: stillbirth, SGA, and PRH. 
 
 
Methods and Analysis Process 
 
Steps in the project are listed below; the methods are described in greater detail for 





Step 1 – Obtained Data on Maternal Address,  
Health Outcomes, and Risk Factors 
 
 After approval of the study by the Institutional Review Boards of the University of Utah 
and the Utah Department of Health (UDOH), the UDOH Office of Vital Records and Statistics 
provided data on maternal address, health outcomes, and risk factors recorded on birth and 
fetal death certificates for the years 1989 to 2006.  
 Other sources of data for risk factors included US Geological Survey elevation data 
(62), Census data for 1990 and 2000 on median family income and median housing value by 




Step 2 – Geocoded Maternal Addresses and  
Geospatially Mapped Each CWS 
 
The UDOH Environmental Epidemiology program provided geocoded maternal 
addresses, which were then reviewed to identify and correct errors. Addresses that had not 
been geocoded were manually geocoded, where possible.  
The UDNR provided a spatial database of boundaries for most CWS service areas. 
Boundaries were updated and refined, and boundaries were added for CWSs not in the 
database, based on publicly available resources, Utah Department of Environmental Quality 
(UDEQ) records, and tax area spatial data available from the Utah Automated Geographic 
Resource Center (62).  
 
 
Step 3 – Estimated Annual Arsenic Concentrations for Each CWS 
 
 The UDEQ provided water quality data from the Safe Drinking Water Information 
System (SDWIS) that included 27,500 arsenic sample results for the years 1978-2007. These 
data were used to estimate annual average arsenic concentrations for each CWS. For years 







Step 4 – Linkage of Data 
 
Geocoded maternal addresses were spatially linked to the CWS in which the address 
was located, and to spatial databases for elevation, census block, and RUCA. Each live birth 
and stillbirth was then linked to the estimated annual arsenic concentration for the year in 
which the first trimester of each pregnancy was estimated to have occurred, based on 
gestational age recorded on vital records. Observations for which no CWS could be assigned 
were then dropped from further analysis as there was no associated water quality data. At this 




Step 5 – Bivariate and Multivariate Analyses 
 
The final step was bivariate and multivariate analyses, including sensitivity analyses 





The three studies are presented in detail in Chapters 2, 3, and 4, followed by a 
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ARSENIC IN COMMUNITY DRINKING WATER SYSTEMS AND  
 






 Exposure to arsenic in drinking water has been associated with several adverse birth 
outcomes. Few studies, however, have investigated the relationship between arsenic exposure 
via drinking water and birth weight, and the results have been inconsistent. Most of these 
studies took place in areas with high levels of arsenic. The purpose of this study was to 
investigate the relationship of low to moderate levels of arsenic in drinking water with small 
for gestational age (SGA) birth. This study included 631,375 births to Utah residents from 1989 
to 2006. Gestational age data from birth certificates were used to identify SGA births based on 
the 10th percentile birth weight by sex for each week of gestation (22 to 44 weeks). Maternal 
addresses, as recorded on birth certificates, were geocoded and spatially linked to 
georeferenced data layers of 476 Community Water System (CWS) service areas statewide and 
to elevation. Births to women who did not reside within a CWS service area, multiple births, 
and infants with birth defects were excluded. Water quality data collected for regulatory 
purposes were used to estimate annual average arsenic levels for each CWS, and these values 
were assigned to each birth based on the conception year and the CWS providing drinking  
water to the residence. There were small but statistically significant associations between 
arsenic concentration and SGA. Using <2.5 µg/L as the referent, the adjusted odds ratio (aOR) 
for SGA was 1.04, (95% confidence interval (CI) 1.00, 1.07) when arsenic levels were 5.1 to 9.9 
µg/L (p-value 0.03), aOR of 1.07 (CI 1.03, 1.12) when levels were 10 µg/L or greater (p-value 





increase in SGA (aOR 1.01, CI 0.98, 1.04). In addition, the frequency of SGA increased with 
every 1,000 feet (ft) increase in elevation. Compared with births at elevations less than 3,000 
ft, the adjusted odds ratio (aOR) for SGA increased with every 1,000 ft gain in elevation, to an 





 Arsenic is a naturally occurring metalloid that primarily enters drinking water sources 
through erosion and dissolution of rocks and minerals (1). Groundwater arsenic levels vary 
across the United States (US), with higher levels found in many areas of the western states. In 
Utah, weathering of volcanic rocks and erosion of slag and soil from past mining activities are 
the major sources of arsenic in groundwater (2, 3). Arsenic levels in drinking water vary  
greatly throughout Utah, ranging from below the limit of detection to over 400 micrograms  
per liter (µg/L) in some private wells (4, 5).  
Humans are exposed to arsenic through intake of food, water, air, and incidental 
ingestion of contaminated soil (6). Arsenic in drinking water is in the inorganic form, which is 
more toxic than the organic form of arsenic generally found in foods. As such, exposure to 
arsenic via ingestion of drinking water is of primary concern (7). In 2001, the US Environmental 
Protection Agency (EPA) adopted a new standard (effective January 2006) that arsenic levels  
in drinking water in community water systems (CWSs) not exceed 10 µg/L, replacing the 
previous maximum contaminant level (MCL) of 50 µg/L (6). 
Chronic exposure to arsenic has consistently been associated with increased incidence 
of cancers, diseases such as Blackfoot disease, and type II diabetes (5, 8-11). The evidence 
linking arsenic exposure with lower birth weight and other adverse birth outcomes has been 
less consistent. Studies in Chile, Taiwan, and Bangladesh each found significant decreases in 
birth weight in areas with arsenic levels in drinking water higher than 40 µg/L, compared with 
areas where arsenic was below detection levels (BD) (12-14). A study in Bangladesh found 
higher prenatal urinary arsenic levels associated with lower birth weight and smaller head and 





exposures ranging from BD to over 300 µg/L and found no association between arsenic and birth 
weight (16), while a study in China found high arsenic levels in drinking  
water (>100 µg/L compared to levels <20 µg/L) to be associated with a 0.5 kilogram increase  
in birth weight (17).  
There are no well-defined biological mechanisms to explain the adverse effects of 
arsenic exposure on fetal growth; however, several modes of effect have been suggested (18). 
Vascular endothelial cells are suspected to be primary targets of arsenic toxicity (19), and 
studies have shown a dose-response relationship between arsenic in drinking water and 
peripheral vascular disease, cerebrovascular disease, and carotid atherosclerosis (20-22). As 
arsenic readily crosses the placental barrier (6, 23) and has been associated with these  
vascular effects, it is possible that arsenic may lead to some type of placental abnormality, 
placental insufficiency, or decreased blood flow, any of which may affect fetal growth (13).   
Small for gestational age (SGA) is generally defined as an infant whose weight at birth 
is less than the 10th percentile for gestational age. It is considered to be a better measure of 
intrauterine growth restriction (IUGR) than birth weight, as it is based on both birth weight  
and gestational age. Severely growth-restricted fetuses are at increased risk for stillbirth and 
neonatal mortality (24). The purpose of this study was to investigate the association between 
maternal exposure to low to moderately elevated levels of arsenic in drinking water and the 





Study Design and Study Population 
This is a retrospective cohort study of SGA births to Utah residents, ages 18 or older, 
who gave birth between January 1, 1989, and December 31, 2006, in Utah, and whose 
residence was provided tap water by a CWS. See Table 2.1 for maternal demographic data. A 
CWS provides water to at least 15 residential service connections or at least 25 people year-
round (25). CWSs are regulated under the Safe Drinking Water Act (SDWA) which requires, 





Table 2.1 Maternal Demographics, SGA Study, Utah, 1989-2006    
               Total#           %          #SGA* %SGA* 
 
Age 
    
18-19 39,041 6.2% 5,799 14.9% 
20-24 203,202 32.2% 23,025 11.3% 
25-29 208,342 33.0% 19,071 9.2% 
30-34 123,406 19.6% 10,094 8.2% 
>34 57,384 9.1% 4,800 8.4% 
Race     
Black 4,229 0.7% 819 19.4% 
Native American 6,983 1.1% 763 10.9% 
White 597,026 95.1% 58,137 9.7% 
Other races 19,441 3.1% 2,673 13.8% 
Hispanic     
Yes 67,990 10.8% 8,260 12.2% 
No 561,651 89.2% 54,339 9.7% 
Education     
<12 years 73,626 11.8% 11,293 15.3% 
12 years 204,804 32.8% 22,671 11.1% 
>12 years 345,140 55.4% 27,940 8.1% 
First pregnancy     
Yes 184,718 29.4% 22,583 12.2% 
No 442,957 70.6% 39,796 9.0% 
Marital status     
Married 539,039 85.4% 48,816 9.1% 
Unmarried 92,335 14.6% 13,973 15.1% 
Previous SGA     
Yes 2,803 0.4%  797 28.4% 
No 628,572 99.6% 61,992 9.9% 
Smoking during pregnancy     
Yes 49,829 7.9% 10,924 21.9% 
No 581,546 92.1% 51,865 8.9% 
Alcohol during pregnancy     
Yes 8,499 1.4% 1,514 17.8% 
No 619,553 98.6% 60,897 9.8% 
Pre-pregnancy BMI     
Lowest 41,078 7.1% 7,124 17.3% 
Normal 352,509 60.9% 35,446 10.1% 
Overweight 112,042 19.4% 8,,942 8.0% 
Obese 73,329 12.7% 5,582 7.6% 
Weight gain for BMI     
Recommended 252,449 40.0% 25,162 10.0% 
Low gain 147,725 23.4% 22,392 15.2% 
High gain 231,201 36.6% 15,235 6.6% 
Elevation at maternal residence     
<3,000 ft 3,707 0.6% 260 7.0% 
3,000-4,000 ft 5,028 0.8% 397 7.9% 
4,000-5,000 ft 554,407 87.8% 54,333 9.8% 
5,000-6,000 ft 57,541 9.1% 6,429 11.2% 








Table 2.1 continued    
          Total#           %     #SGA* %SGA* 
     
Metropolitan 522,640 82.8% 50,568 9.7% 
Metropolitan adjacent 42,144 6.7% 4,543 10.8% 
Small town 39,565 6.3% 4,594 11.6% 
Rural 27,022 4.3% 3,084 11.4% 
* SGA defined as 10th percentile birth weight at gestational weeks 22-44 based on Utah 






Birth certificate data were obtained from the Utah Department of Health (UDOH) 
Office of Vital Records and Statistics upon approval from the Institutional Review Boards of the 
UDOH (Project #226) and the University of Utah (Project #00023217).  
SGA was defined as an infant whose weight at birth is less than the 10th percentile, 
stratified by sex, for each week of gestational age (weeks 22 to 44), based on the distribution 
of birth weight and gestational age reported on Utah birth certificates during the study time 
period (Table 2.2). Gestational age recorded on the birth certificate was determined by the 
birth attendant based on available data such as last menstrual period, prenatal visits, 
ultrasound data, and/or newborn examination. The sample size for analysis was 631,375 births 
(Figure 2.1). 
 Multiple births and infants with birth defects were excluded, as were infants with non-
plausible birth weights (<250 grams or >6,000 grams), assumed to be errors in recording. 
Infants with a recorded gestational age of less than 22 weeks were excluded, as births prior to 
22 weeks are rarely viable, and infants with a gestational age greater than 44 weeks were 
excluded, as births are usually induced by 44 weeks gestation (Figure 2.1). Births were also 
excluded from the study if a) birth weight and/or gestational age were not reported on the 
birth certificate; b) no address was reported on the birth certificate; c) the address was 
outside of a CWS service area; d) address information was inadequate to identify whether the 
maternal address at the time of birth was within the boundaries of a CWS; e) the address was 
within the service area of a CWS on tribal lands, but water quality data were not available; f) 
the mother was not a Utah resident; g) the birth was not in Utah; and h) if the birth occurred 
in 1990, as addresses were not available electronically for that year.  Of the 725,014 Utah 
births to women age 18 or older in 1989-2006, 93,639 (12.9%) were excluded from the study. 
 
 
Exposure Assignment  
 
 Tap water arsenic concentrations for each birth were based on arsenic concentrations 
reported to the Utah Department of Environmental Quality (UDEQ) by the CWS that served the 





Table 2.2 Births by Gestational Age, SGA 10th Percentile Counts, and Weight  
Thresholds by Sex in Utah, 1989-2006         
   SGA  SGA weight 
Gestation                  10th percentile         threshold (grams)    















23 202 19 10 9 485 430 
24 259 23 13 10 510 468 
25 289 27 14 13 600 539 
26 359 33 19 14 680 579 
27 412 40 23 17 750 645 
28 520 50 29 21 852 810 
29 642 61 32 29 964 879 
30 860 85 48 37 1,115 1,029 
31 1,154 115 65 50 1,270 1,234 
32 1,748 174 97 77 1,484 1,385 
33 2,800 279 157 122 1,685 1,637 
34 5,280 526 298 228 1,949 1,835 
35 9,748 972 528 444 2,103 2,085 
36 21,974 2,162 1,172 990 2,410 2,296 
37 51,140 5,084 2,714 2,370 2,623 2,520 
38 123,595 12,354 6,398 5,956 2,827 2,715 
39 200,071 19,987 10,140 9,847 2,974 2,857 
40 139,821 13,898 6,941 6,957 3,060 2,940 
41 51,267 5,013 2,439 2,574 3,090 2,980 
42 12,267 1,205 599 606 3,033 2,920 
43 4,500 450 220 230 2,929 2,847 
44 2,234 218 105 113 2,920 2,850 


























Figure 2.1 SGA Exclusion and Inclusion Criteria, Utah, 1989-2006 
  
Births in Utah to Utah 
residents age 18 or older  
= 725,014 
Excluded – 25,566 not geocoded 
12,134 geocoded, but not in     
community water system 
 14,797 geocoded, but no arsenic data 
672,098 Births geocoded and 
within community water 
system boundaries 
Excluded – 17,680 Multiple births 
        16,953 Infants with birth defects 
 3,856 Missing data on birthweight and/or 
gestational age 
 2,653 Out-of-range for birthweight 
and/or gestational age 





The UDOH provided geocoded coordinates for many of the addresses. We reviewed 
these results to identify and correct errors. Addresses that had not been geocoded by UDOH 
were manually geocoded to specific addresses where possible using ArcGIS® 9.3 (ESRI, 
Redlands, CA). Where only the city and zip code were available, but the mother indicated she 
lived within the city limits: 1) the residence was geocoded to the center of the city (if only one 
CWS provided service in that city); or 2) the residence was geocoded to the zip code delivery 
centroid within the city limits (if more than CWS provided service within the city). Where there 
was no street address (or the address was a post office box) and the mother indicated that she 
lived outside the city limits, the mother was assumed to live outside the limits of the CWS 
service area and was, therefore, excluded.  
Over 97% of the maternal addresses in each county were geocoded with sufficient 
precision to determine their location inside or outside of specific CWS service areas. 
Each geocoded residential address was linked spatially to a CWS based on the reported 
boundaries of the CWS service area. The Utah Department of Natural Resources (UDNR) 
provided a spatial database of most of the CWS boundaries statewide. Many of the boundaries, 
however, were not based on legal descriptions, did not include water systems regulated by the 
Utah Public Utilities Commission, and did not include systems that had closed prior to 2007. 
The service areas for each water system were reviewed and updated using water system maps; 
legal descriptions of boundaries; UDEQ records on mergers, changes in boundaries, ownership, 
system names, and/or CWS numbers; and tax area boundaries (water systems, subdivisions,  
and municipalities) provided by the Utah Automated Geographic Reference Center (26). 
Records from the UDEQ were of particular importance for mapping CWSs that had closed at 
some point during the study time period and had not been mapped by other agencies. CWS 
boundaries and subdivision plat maps were also obtained through on-line searches of websites 
for county assessors, subdivisions, and municipalities. When questions remained regarding 
service area boundaries, water systems were contacted by phone and/or in person to verify  





Where different water sources clearly served specific areas of a CWS service area and 
these sources had significantly different arsenic levels, the service area was divided into 
regions that were treated as independent service areas.  
Through this process we identified and developed boundaries for 58 CWSs that were  
not in the original UDNR database, and made modifications to over two-thirds of the CWS 
boundaries we had obtained from the various sources. The 12 water systems that are/were 
wholesalers to other CWSs and did not directly provide water to any residential connections 
were not mapped. We were unable to find information on service area boundaries and water 
quality data for 13 closed, small water systems, so these systems were also not mapped. Areas 
served by tribal water systems (who reported sample data to the US EPA and not to the UDEQ) 
were excluded from this study, except for those years where water quality data was available 
on-line for tribal systems. 
Water quality data from the Safe Drinking Water Information System (SDWIS) for Utah 
water systems from 1978–2006, including 27,500 arsenic sample results, were provided by the 
UDEQ. We used this database to identify the specific water system (and/or wholesale water 
system) and sample data for each exposure year for which sample data had been reported to 
the UDEQ. While some CWSs had consistent water sources for the entire time period, others 
supplied groundwater or surface water from local sources in some years but became purchasers 
in later years due to regional consolidation or to improve water quality. We used these data to 
estimate annual average arsenic concentrations for each CWS. When there was no sample 
result for a given year in the time period that the CWS was providing service, we used linear 
interpolation or extrapolation. 
Many CWSs blend water from various groundwater and/or surface water sources that 
may have very different arsenic levels. In such cases all results from each source in a given 
year were first averaged, and the average values for each source were then averaged across all 
sources for that CWS in that year. Some water sources are only used seasonally; however, data 
on the production from each source and the number of days the source was utilized were not 





all sources were assumed to have contributed equally. Data from wells classified as „inactive‟ 
in the UDEQ dataset were not used, except in those cases where the date that the well became 
inactive was available.  
Within each CWS, reported arsenic levels were generally consistent across time. The 
greatest variability was seen in results reported as BD, as reported detection limits ranged 
from 0 to 50 µg/L. These differences in detection limits were primarily due to changes in 
reporting requirements over time, but were also due to the use of different laboratories within 
the same time periods.  
Where a system reported that a sample value was BD, we generally assigned the 
sample a value of half of the censoring level. Where detection limits were reported as greater 
than the current maximum contaminant level (MCL) (10 µg/L), we reviewed the sample values 
for the source in later years, as well as the general arsenic levels from similar sources in the 
immediate area to determine the appropriate value to assign to that sample. A few 
groundwater systems, for example, had consistently low levels of arsenic for most years (<2.5 
µg/L), but reported a few BD results as having a detection level of 50 µg/L. Where a BD was 
reported as 50 µg/L in a system where all other sources and all other years of sampling were 
very low, assigning a value of 25 µg/L would result in an estimated arsenic concentration over 
twice the current MCL. In these instances we reviewed the UDEQ records and Consumer 
Confidence Reports (CCRs) for the systems and assigned an arsenic sample value that more 
accurately represented arsenic levels for that year for that CWS. 
All annual sample values assigned to each system were coded to identify whether the 
annual value was based on all samples having specific detection values, or all samples being BD 
values, or samples with a mix of specific and BD values, or an annual value that was adjusted 
based on review of UDEQ records and/or CCRs. To address these differences in precision of 
reporting levels, as well as the potential error in assigning values by time trends based on the 
3-year reporting cycles, we conducted sensitivity analyses. 
Each birth was then linked to the estimated annual average arsenic concentration for 





based the gestational age reported on the birth certificate. Because of the known relationship 
between elevation of residence and decrease in birth weight (27-29), births were also linked to 
a digital elevation model (90 meter grid) from the US Geologic Survey (30). Births were also 
linked to median income and median housing values for the census block group for 1990 and 
2000 (31), and Rural-Urban Commuting Area Codes for 1990 and 2000, based on the location of 
the maternal residence (32). Births that occurred before 1995 were assigned the value 






The individual births are the units of analysis for this study. The relationship between 
levels of arsenic in drinking water and the birth outcomes were assessed using bivariate 
analyses and multivariate logistic regression. The measure of effect was the relative risk for 
each outcome, adjusted for potential confounders. Statistical Analysis Systems software, 
version 9 (SAS, Cary NC) and Stata version 10 (Stata Corporation, College Station, TX) were 
used for data reduction and statistical analyses.   
We examined the distributions of the health outcomes and covariates, examined the 
relationships between the covariates to identify potential collinearity, and assessed the 
bivariate relationships between risk factors and SGA. Covariates were identified as potential 
confounders if they were associated with both arsenic exposure and SGA at a significance level 
of p-value < 0.2 in bivariate analyses. Potential confounders and known risk factors were 
included in the initial main effects models. Risk factors that have been associated with SGA 
that were assessed in initial models included maternal age, low maternal weight gain, low pre-
pregnancy weight, previous SGA, smoking, alcohol use, maternal height, elevation at maternal 
residence, maternal race/ethnicity, chronic hypertension, parity, pregnancy related 
hypertension, renal disease, and socioeconomic status. Proxy measures that were used for 
socioeconomic status were years of education, and the median income and median housing 





Elevation was categorized into 1,000 foot intervals. Arsenic concentration was assessed 
both as a continuous variable and as a categorical variable. We conducted sensitivity analyses 
to assess the effects of our assumptions in creating annual average concentrations on the 
resulting associations with SGA. Finally, interaction terms were tested for significant covariates 
that previous studies or etiology suggested had the potential for effect modification.  
Stepwise procedures, followed by diagnostic tests, including likelihood ratio tests, 
were used to assess significance and goodness-of-fit after the addition of each covariate. The 
statistical significance of the estimated parameters was assessed using two-sided tests with an 





Compared with arsenic levels less than 2.5 µg/L, there was a small but statistically 
significant increase in SGA for arsenic levels at 5.1-9.9 µg/L, with an adjusted odds ratio (aOR) 
of 1.04, 95% confidence interval (CI) 1.00, 1.07 (p-value 0.03); and at levels 10 µg/L or greater, 
with an aOR of 1.07, 95% CI: 1.03, 1.12 (p-value 0.002). At arsenic levels from 2.5-5 µg/L, 
there was a small, but not statistically significant, increase in SGA with an aOR of 1.01  
(CI 0.99, 1.04). Over 87% of the arsenic exposure levels were 5 µg/L or less. The median 
exposure level in the highest arsenic category was 11.7 µg/L (mean 13.0 µg/L). Only 142 of  
the maternal residences (0.02% of the study population) were in CWS service areas that had 
estimated arsenic levels greater than 40 µg/L; the highest exposure level was 126.1 µg/L. 
Because a dose-effect association might be more pronounced in newborns that are 
more severely growth restricted, we repeated the analysis using a gender-specific birthweight-
gestational age calculation at the 5th percentile (n=31,387). The association between arsenic 
and SGA was somewhat stronger in these infants; compared with arsenic at levels <2.5 µg/L, 
the aOR for 2.5-5.0 µg/L was 1.05, 95% CI 1.01, 1.09 (p-value 0.01); the aOR for 5.1 to 9.9  
µg/L was 1.08, 95% CI 1.03, 1.13 (p-value 0.001); and the aOR for levels of 10 µg/L or greater 





As arsenic levels were interpolated for years when sampling was not required and/or 
was not reported to UDEQ, we repeated the analysis first excluding interpolated values, and 
then excluding all BD values. In each of the follow-up analyses, increased arsenic levels were 
significantly associated with increased rates of SGA, and the aORs were essentially the same.  
See Table 2.3 for the covariates included in the final model. The majority of the 
residences were in urban areas (83%) and were at less than 5,000 feet elevation. Over 55% of 
the population had more than 12 years education, and over 37% of the mothers were age 18–24. 
The racial distribution differed from the US population (2000 Census), with 95.1% White 
(compared with 75.1% US) and 0.7% Black (compared with 12.3% US) (31). The study population 
was 10.8% Hispanic, compared with 12.5% US. Less than 9% of the women reported smoking, 
compared with the 23% national estimate in 2000 (33). 
The frequency of SGA increased with every 1,000 feet increase in elevation, controlling 
for the covariates. Women residing above 6,000 feet had almost twice the risk of a having an 
SGA baby as compared to women residing below 3,000 feet (aOR 1.90, CI 1.64, 2.19). Even 
women living at moderate elevations, where the  major population centers are situated 
(elevation 4,000 to 5,000 ft), were 1.37 times more likely to have an SGA baby than women 
residing at lower elevations (95% CI 1.20, 1.56).  
As expected, risk of SGA was significantly higher for women with lower body mass 
index (BMI), women less than 5 feet tall, for those with lower weight gain than recommended 
for their BMI, for those who reported smoking or alcohol use during pregnancy, and for women 
with less than 12 years education. Women who had an SGA birth were three times as likely to 
have had a previous SGA birth as women who did not have an SGA birth (CI 3.06, 3.69). Risks 
were increased in non-White races, and in women with placenta previa, abruptio placenta, 
pregnancy-related hypertension, and/or chronic hypertension.  
There was a significant interaction between mother‟s age and parity. Of births to 
women age 18-19, 14.9% were SGA, with overall rates decreasing with increasing age; only 
8.2%-8.4% of the births to women over age 29 were SGA. SGA risk was also higher in nulliparous 





Table 2.3 Risk Factors for Population-Specific SGA Included in Final Model, Utah, 1989-2006  
 Total # % #SGA* %SGA*  aOR 95% CI 
 
Arsenic in Drinking Water 
      
<2.5 µg/L (ref) 466,658 73.9% 45,868 9.8%   
2.5-5.0 µg/L  88,663 14.0% 8,755 9.9% 1.01 (0.99, 1.04) 
5.1-9.9 µg/L  52,710 8.4% 5,645 10.7% 1.04 (1.00, 1.07) 
>9.9 µg/L 23,344 3.7% 2,521 10.8% 1.07 (1.03, 1.12) 
Elevation at maternal residence       
<3,000 ft (ref) 3,707 0.6% 260 7.0%   
3,000-4,000 ft 5,028 0.8% 397 7.9% 1.08 (0.91, 1.28) 
4,000-5,000 ft 554,407 87.8% 54,333 9.8% 1.37 (1.20, 1.56) 
5,000-6,000 ft 57,541 9.1% 6,429 11.2% 1.60 (1.40, 1.83) 
>6,000 ft 10,585 1.7% 1,359 12.8% 1.90 (1.64, 2.19) 
Smoking during pregnancy       
Yes 49,829 7.9% 10,924 21.9% 2.46 (2.39, 2.53) 
No (ref) 581,546 92.1% 51,865 8.9%   
Maternal Race       
Black 4,229 0.7% 819 19.4% 1.92 (1.77, 2.10) 
Native American 6,983 1.1% 763 10.9% 1.03 (0.95, 1.12) 
White (ref) 597,026 95.1% 58,137 9.7%   
Other races 19,441 3.1% 2,673 13.8% 1.44 (1.38, 1.51) 
Hispanic       
Yes 67,990 10.8% 8,260 12.2% 1.09 (1.06, 1.12) 
No (ref) 561,651 89.2% 54,339 9.7%   
Previous SGA       
Yes 2,803 0.4% 797 28.4% 3.37 (3.06, 3.69) 
No (ref) 628,572 99.6% 61,992 9.9%   
Maternal age       
18-19 39,041 6.2% 5,799 14.9% 1.17 (1.11, 1.25) 
20-24 203,202 32.2% 23,025 11.3% 1.11 (1.08, 1.15) 
25-29 (ref) 208,342 33.0% 19,071 9.2%   
30-34 123,406 19.6% 10,094 8.2% 0.93 (0.91, 0.96) 
>34 57,384 9.1% 4,800 8.4% 0.96 (0.92, 1.00) 
Pregnancy-related hypertension       
Yes 31,527 5.0% 4,934 15.7% 2.10 (2.03, 2.17) 
No (ref) 599,848 95.0% 57,855 9.6%   
Chronic hypertension       
Yes 3,081 0.5% 434 14.1% 1.75 (1.56, 1.96) 
No (ref) 628,294 99.5% 62,355 9.9%   
Mother less than 5 feet tall       
Yes 72,489 11.5% 9,980 13.8% 1.81 (1.75, 1.88) 
No (ref) 558,886 88.5% 52,809 9.5%   
Weight gain for BMI       
Recommended 252,449 40.0% 25,162 10.0%   
Low gain 147,725 23.4% 22,392 15.2% 1.60 (1.57, 1.63) 
High gain 231,201 36.6% 15,235 6.6% 0.61 (0.59, 0.62) 
First pregnancy       
Yes 184,718 29.4% 22,583 12.2% 1.60 (1.55, 1.66) 
No (ref) 442,957 70.6% 39,796 9.0%   
Pre-pregnancy BMI       
Lowest 41,078 7.1% 7,124 17.3% 1.51 (1.46, 1.55) 
Normal 352,509 60.9% 35,446 10.1%   
Overweight 112,042 19.4% 8,,942 8.0% 0.88 (0.86, 0.90) 





Table 2.3 continued       
 Total # % #SGA* %SGA* aOR 95% CI 
       
Abruptio placenta       
Yes 6,767 1.1% 1,066 15.8% 1.45 (1.35, 1.57) 
No (ref) 624,608 98.9% 61,723 9.9%   
Placenta previa       
Yes 2,401 0.5% 307 12.8% 1.28 (1.12, 1.47) 
No (ref) 628,974 99.5% 62,482 9.9%   
Education       
<12 years 73,626 11.8% 11,293 15.3% 1.12 (1.08, 1.15) 
12 years (ref) 204,804 32.8% 22,671 11.1%   
>12 years 345,140 55.4% 27,940 8.1% 0.83 (0.81, 0.85) 
Marital status       
Married I(ref) 539,039 85.4% 48,816 9.1%   
Unmarried 92,335 14.6% 13,973 15.1% 1.15 (1.12, 1.18) 
Alcohol during pregnancy       
Yes 8,499 1.4% 1,514 17.8% 1.18 (1.10, 1.27) 
No 619,553 98.6% 60,897 9.8%   
 
Age-First Pregnancy Interaction       
Age<20, first pregnancy 26,685 69.2% 3,987 14.8% 0.74 (0.69, 0.81) 
   Age<20, not first 11,942 30.8% 1,781 14.9%   
Age 20-24, first pregnancy 94,167 46.6% 10,966 11.7% 0.82 (0.78, 0.86) 
   Age 20-24, not first 107,952 53.4% 11,922 11.0%   
Age 25-29, first pregnancy 46,319 22.4% 5,330 11.5%   
   Age 25-29, not first 160,844 77.6% 13,618 8.5%   
Age 30-34, first pregnancy 13,010 10.6% 1,671 12.8% 1.18 (1.10, 1.27) 
   Age 30-34, not first 109,600 89.4% 8,334 7.6%   
Age >34, first pregnancy 4,337 7.6% 629 14.5% 1.28 (1.15, 1.42) 
   Age >34, not first 52,619 92.4% 4,141 7.9%   
* SGA defined as 10th percentile birth weight at gestational weeks 22-44 based on Utah births in  










In nulliparous women over age 34, however, 14.5% of births were SGA, compared with 7.9% of 
births to multiparous women over age 34.  In nulliparous women ages 30-34, 12.8% of births 
were SGA, compared with 7.6% of births to multiparous women ages 30-34. In women ages 18-
24, SGA rates in nulliparous women were comparable to those of multiparous women. SGA 
rates were highest in nulliparous women ages 18-19 and in those older than age 34.  
The overall mean arsenic levels for 1989-2006, source (surface or groundwater), and 
location (metropolitan or nonmetropolitan) for the 476 CWSs included in the study are shown in 
Table 2.4. A higher proportion of CWSs that relied on groundwater (7%) had an average 
concentration of 10 µg/L or greater compared with systems supplied primarily by surface water 





 After adjusting for multiple potential confounders and other risk factors for SGA, 
arsenic was associated with a small, but statistically significant, increased risk of SGA. While 
the effect levels are modest, the ability to control for a large number of potential confounders 
and known risk factors reduces the chance that these results are due to uncontrolled 
confounding. In addition, the large sample size and substantial gradient of arsenic exposure 
levels allowed us to demonstrate moderately small, but statistically significant, effects.   
This is one of the first studies to examine the relationship of arsenic in drinking water 
to SGA births. Six studies that examined the association of arsenic with lower birth weight had 
disparate results; four studies found arsenic to be a significant risk factor for lower birth 
weight, one found no association, and the remaining study found arsenic exposure to be a 
protective factor (11-15). While the effect estimates in the studies that did find an association 
were larger than those found in this study, the upper exposure levels were much higher as well 
(50–400 µg/L). 
We also found a strong relationship between elevation and the risk of SGA birth, 
consistent with past studies. To our knowledge, this is one of the first studies, however, to 





Table 2.4 Overall Mean Arsenic Concentrations (1989-2006) by Community Water System 




































2.5-5 116 24% 16 18% 100 26% 21 18% 95 27% 
5.1-9.9 43 9% 4 4% 39 10% 8 7% 35 10% 
>9.9 27 6% 2 2% 25 6% 5 4% 22 6% 




(1,000 ft). Elevation was also more accurately assigned since it was determined by residential 
address and not by county or census block location. Increased rates of SGA at high altitude are 
generally attributed to chronic hypoxia; however, the mechanisms by which hypoxia acts to 
reduce fetal growth are not well understood (27-29).  
There were statistically significant relationships between many of the known risk 
factors and SGA, and the observed associations were as expected. Of particular interest was 
the modification of the effect of age depending on parity. Although SGA risk was lowest in 
women age 30 and above and highest in those under age 25, SGA risk was highest in nulliparous 
women older than 34 and lowest in women younger than 25.  
SGA was increased in Hispanics and certain racial groups; however, this increase may 
be due to the much higher frequency of short stature. Many of these infants, though 
technically classified as SGA, may be an appropriate weight for gestational age due to the 
height of the mother and race/ethnicity.    
The most significant limitations of this study are related to arsenic exposure 
assignment. As this was a retrospective study, we did not have any information about water 
consumption patterns. Thus, our method assumes uniform water consumption rates across 
individuals and over time, and that women who resided in an area served by a CWS drank tap 
water (not filtered by reverse osmosis) from that system.   
The number of samples and number of years of sample collection varied greatly by 





annually, while groundwater systems are required to report arsenic levels every three years (or 
more frequently if arsenic levels are above the EPA MCL). While most systems provided water 
service throughout the study period some CWSs were created in later years of the study period 
to provide service to newly created subdivisions, while others were not required to report 
arsenic levels due to a drop in the population served (common in mobile home parks). The use 
of BD values was also problematic, as they varied between and within years for different 
systems. These factors lead to exposure errors that cannot be quantified. Our sensitivity 
analyses, however, showed very little change in results using more stringent assumptions. 
An additional limitation is that arsenic levels from all sources within a system were 
averaged to determine an annual arsenic level. Factoring in the timing and quantity of water 
from each source would provide a more accurate arsenic estimate. Review of individual water 
system records beyond that available in the SDWIS database was beyond the scope of this 
study. 
We also did not know the length of time that women resided in the CWS providing 
service at the time of delivery. Residential mobility during pregnancy, reported in other  
studies to range from 20 to 30%, is an additional unknown (33-35). Most moves have been  
found to be in same general area.  While a study of exposure to air contaminants would likely 
not be impacted by a move of a few miles, a move as little as across the street could result in  
a change of water system.  
Errors in the exact boundaries of the CWS service areas, and in the geocoded locations 
of the maternal residence, would also affect the results. The large sample size, and efforts to 
validate CWS boundaries and residential locations, likely minimized any systematic errors that 
would result from these inaccuracies. 
There is some limitation in generalizability due to the Utah population being 
predominantly White, with over half of the Utah population members of The Church of Jesus 
Christ of Latter Day Saints who follow religious proscriptions against alcohol and tobacco use, 





and racial distribution differed (31, 33), in Utah compared with the US, the statistical 
significance of these risk factors was comparable to results from other studies.   
Women who gave birth to more than one child during the 17-year study period were 
included in this study for each pregnancy. While some women lived in one CWS for all 
pregnancies, other women moved one or more times and may, or may not, have been exposed 
to differing levels of arsenic during subsequent pregnancies due to these moves. As risk may 
increase with chronic arsenic exposure, additional studies are recommended that assess 
residential mobility in terms of CWS exposure levels.   
This study included all eligible births over a 17-year period, and used an SGA scale 
derived from Utah births. CWS service areas were carefully researched, and the assignment of 
maternal address to CWS was based on geocoding of actual street address. We thus expect 
there to be little error in linking arsenic levels to individuals. Further, most of the major  
known risk factors were included in the analysis. This adds credibility to the small but 
statistically significant associations with arsenic levels.  
This study assessed exposure to arsenic levels common in populations where drinking 
water is supplied by a CWS. Women who lived outside of areas served by a CWS were not 
included in the analysis. In many areas of Utah, groundwater arsenic levels are among the 
highest in the US, with some even approaching those seen in heavily arsenic-impacted areas 
such as Bangladesh [4]. Additional studies are recommended in these areas to better elucidate 
the relationship of SGA at high arsenic levels, and to provide a basis for actions to reduce risk 
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ARSENIC IN COMMUNITY DRINKING WATER SYSTEMS 
  






Chronic exposure to high levels of arsenic has been associated with a number of 
cancers and diseases, including Blackfoot Disease, Type II diabetes, and, in some studies, 
hypertension. The purpose of this study was to investigate whether exposure to low to 
moderate levels of arsenic in drinking water is associated with pregnancy-related hypertension. 
Maternal addresses at time of delivery were geocoded for over 650,000 births to Utah residents 
during 1989–2006. Annual average arsenic levels were estimated for 476 Utah community water 
systems (CWSs) using monitoring data submitted to the Utah Department of Environmental 
Quality. Arsenic levels for each CWS were assigned to each birth based on conception year by 
linking geocoded addresses to georeferenced CWS service areas. The level of arsenic was not 
associated with increased risk of pregnancy-related hypertension in a model that adjusted for 
parity, body mass index, diabetes, weight gain, and other risk factors. Compared with tap 
water arsenic concentrations less than 2.5 micrograms per liter (µg/L), the adjusted odds ratio 
(aOR) for those with 2.5–5 µg/L was 0.97, 95% confidence interval: 0.93, 1.00; for those 
exposed to 5–10 µg/L, aOR 0.98, 95% confidence interval: 0.94, 1.02; and for those exposed to 





Arsenic is a naturally occurring element, widely distributed in the Earth‟s crust (1). 





eruptions, mining processes, pesticide application, coal and wood combustion, and waste 
incineration. Arsenic enters drinking water sources primarily through erosion, runoff, and 
leaching (1, 2). For most people, diet is the largest source of arsenic exposure, with additional 
exposure through drinking water, air, and incidental ingestion of contaminated soil (1). 
Exposure to arsenic in drinking water, however, is of primary concern since arsenic in drinking 
water is in the more toxic inorganic form, while arsenic in food sources is primarily the less 
toxic organic form of arsenic (3).  
Groundwater arsenic levels vary widely across the United States (US), with higher 
levels in certain areas of many western states (4). In Utah, arsenic levels in drinking water 
range from below the limit of detection (BD) to over 400 micrograms per liter (µg/L) in some 
private wells (5, 6). Arsenic in Utah groundwater is primarily due to erosion of volcanic rock 
and to runoff and leaching in former mining and smelting areas (4, 6). The maximum 
contaminant level (MCL) for arsenic in community drinking water, as of January 2006, is 10 
µg/L; the previous MCL was 50 µg/L (1). 
Several adverse health outcomes have been linked to chronic exposure to arsenic, 
including cancers of the bladder, skin, lung, kidney, and liver, cardiovascular disease, and 
Blackfoot disease (1, 7-10). Studies in Taiwan, Bangladesh, and China found that hypertension 
was increased in populations exposed to arsenic levels as low as 21-50 µg/L in drinking water 
(11-14). Researchers in Bulgaria found elevated prevalence of preeclampsia (8.0 vs. 2.5 per 
1,000 births) in women exposed to arsenic and other metals in air near a copper smelter (15-
17). Placental arsenic content was also three times higher compared with those in the non-
smelter area (16). 
Pregnancy-related hypertension (PRH) includes preeclampsia and eclampsia. 
Preeclampsia, which occurs in 5% to 8% of pregnancies, is characterized by hypertension 
associated with proteinuria (18, 19). Eclampsia is the occurrence of seizures in women with 
signs and symptoms of preeclampsia. PRH generally occurs after 20 weeks gestation, and is 
implicated in preterm birth, perinatal morbidity and mortality, abruptio placenta, and 





Inorganic arsenic readily crosses the placental barrier (1, 21), and several mechanisms 
by which arsenic may impact PRH have been suggested (22). Vascular endothelial cells are 
suspected to be primary targets of arsenic toxicity (23). Damage to the endothelium can result 
in edema and hemorrhage in various tissues and may increase the risk of preeclampsia (24). 
Arsenic has also been linked with inhibition of angiogenesis, defective placental vasculogenesis, 
and placental dysmorphogenesis, which may result in placental insufficiency (25). Arsenic has 
been shown to induce oxidative stress in the placenta (26, 27) and has been found to be 
elevated in placentas of women who live near smelters (15, 17). In preeclampsia, there is a 
partial failure in the placentation process, with reduced invasion of the spiral arteries by 
trophoblast (18) which may be due in part to increased oxidative stress (28).   
The purpose of this study was to investigate whether there is an association between 
PRH and exposure to low to moderately elevated levels of arsenic in drinking water in a large, 





Study Design and Study Population 
  
This is a retrospective cohort study of PRH in Utah residents, ages 18 or older, who had 
a live birth or stillbirth between January 1, 1989, and December 31, 2006, in Utah, and whose 
residence at the time was delivery was within the boundaries of a Community Water System 
(CWS). A CWS, as defined by the US Environmental Protection Agency (EPA), provides water to 
at least 15 residential service connections or at least 25 people year-round (29). The Safe 
Drinking Water Act requires that CWSs regularly monitor water quality, including arsenic levels. 
Maternal demographic data are presented in Table 3.1. 
Upon approval of the study protocol by the Institutional Review Boards of the Utah 
Department of Health (UDOH) (Project #226) and the University of Utah (Project #00023217), 
the UDOH Office of Vital Records and Statistics provided birth and fetal death certificate data. 
For this study, PRH was based on the fields „Pregnancy-Associated Hypertension‟ and/or 





Table 3.1 Maternal Demographics, PRH Study, Utah, 1989-2006                       
 Total# % #PRH %PRH 
 
Age 
    
18-19 41,480 6.1% 2,276 5.5% 
20-24 216,131 32.0% 12,102 5.6% 
25-29 222,646 32.9% 10,951 4.9% 
30-34 132,951 19.7% 6,183 4.7% 
>34 62,609 9.3% 3,641 5.8% 
Race     
Black 4,652 0.7% 219 4.7% 
Native American 7,499 1.1% 537 7.2% 
White 639,057 95.1% 33,422 5.2% 
Other races 20,676 3.1% 782 3.8% 
Hispanic     
Yes 72,416 10.7% 3,329 4.6% 
No 601,557 89.3% 31,737 5.3% 
Education     
<12 years 80,237 12.0% 3,566 4.4% 
12 years 218,551 32.8% 11,913 5.5% 
>12 years 368,454 55.2% 19,232 5.2% 
First pregnancy     
Yes 195,345 29.1% 15,002 7.7% 
No 476,198 70.9% 19,980 4.2% 
Marital status     
Married 576,848 85.4% 29,733 5.2% 
Unmarried 98,947 14.6% 5,422 5.5% 
Multiple pregnancy     
Yes 18,041 2.7% 2,081 11.5% 
No 657,702 97.3% 33,071 5.0% 
Pre-pregnancy BMI     
Lowest 43,692 7.1% 1,090 2.5% 
Normal 374,801 60.7% 14,233 3.8% 
Overweight 119,783 19.4% 8,352 7.0% 
Obese 79,178 12.8% 8,736 11.0% 
Smoking during pregnancy     
Yes 53,500 7.9% 2,204 4.1% 
No 622,208 92.1% 32,944 5.3% 
Alcohol during pregnancy     
Yes 9,109 1.4% 424 4.7% 
No 662,355 98.6% 34,488 5.2% 
Elevation at maternal residence     
<3,000 ft 3,994 0.6% 208 5.2% 
3,000-4,000 ft 5,445 0.8% 295 5.4% 
4,000-5,000 ft 592,930 87.8% 30,228 5.1% 
5,000-6,000 ft 61,965 9.2% 3,682 5.9% 
>6,000 ft 11,378 1.7% 739 6.5% 
Rural/Urban Commuting Area     
   Metropolitan 558,724 82.7% 28,854 5.2% 
   Metropolitan adjacent 45,463 6.7% 2,357 5.2% 
   Small town 42,632 6.3% 2,338 5.5% 








eclampsia)‟ on fetal death certificates. We reviewed text fields on birth and fetal death 
records to identify and include cases of preeclampsia, eclampsia, or toxemia that had not been 
indicated as such in check box fields. Chronic hypertension was indicated in a separate field in 
the vital records and was not included in the definition of PRH for this study, as the focus of 
this study was on hypertension that began during pregnancy, and that included other diagnostic 
criteria such as proteinuria, edema, and/or seizures. 
Non-resident births in Utah and births to Utah residents outside of Utah were excluded 
from the study, as were births that occurred in 1990 because addresses were not available on 
the electronic birth files for that year. Other exclusions included births a) with no address 
reported on the birth or fetal death certificate; b) with an address outside of a CWS service 
area; and c) where the address was within a CWS on tribal lands and water quality information 
was not available. Of the 725,014 Utah live births to women age 18 or older in 1989-2006, 
52,916 (7.3%) were excluded from the study; 211 (5.4%) of the 3,943 stillbirths were also 





 The UDOH provided geocoded coordinates for many of the maternal addresses, which 
were then reviewed to identify and correct errors. We then manually geocoded, where 
possible, the remaining addresses using ArcGIS 9.3 (ESRI, Redlands, CA). Addresses that 
included only a city and zip code, but the vital records identified that the woman lived within 
city limits were 1) geocoded to the center of the city, or 2) were geocoded to a zip code 
delivery centroid if more than one CWS provided service. Over 97% of the maternal addresses  
in each county were geocoded with sufficient precision to determine their CWS, or that they 
were outside of the boundaries of a CWS. 
The Utah Department of Natural Resources (UDNR) provided a spatial database of most 
of the CWS boundaries statewide that had been created by the UDNR to provide the public with 
a general idea of CWS service areas. We reviewed each CWS boundary and revised boundaries, 






Live births in Utah to Utah 
residents age 18 or older = 
725,014 
Excluded - 25,985 not geocoded 
 12,134 geocoded not in water system 
                14,797 geocoded but no arsenic data 
672,098 live births geocoded and 
within community water system 
boundaries 
Stillbirths in Utah to Utah residents 
age 18 or older = 3,943 
Excluded – 53 not geocoded 
                 71 geocoded not in water system 
                 87 geocoded but no arsenic data 
3,732 stillbirths geocoded and 
within community water system 
boundaries 
675,830 pregnancies (live births & stillbirths) 
included in study 
Figure 3.1 Pregnancy-Related Hypertension - Exclusion and Inclusion Criteria for Live Births 





maps, and subdivision plat maps); legal descriptions of boundaries; Utah Department of 
Environmental Quality (UDEQ) electronic records of maps, mergers, boundary revisions, 
changes in ownership or system names,; and tax area boundaries (including municipalities, 
subdivisions, and several water systems) provided by the Utah Automated Geographic 
Reference Center (30). In reviewing the records of one CWS, we found that the CWS had seven 
regions that had differing water sources; a few of these areas had arsenic levels at 10-15 µg/L, 
while in other areas the arsenic levels were BD. As a result, we created seven different maps 
for the one CWS to more accurately assign arsenic exposures. 
Through these various mapping sources, we were able to add 58 CWSs to the UDNR 
spatial database, and to refine the boundaries of over two-thirds of the CWS boundaries from 
the various sources. There were 13 systems (now closed) that were not mapped due to being 
unable to find any information on their boundaries. Twelve systems that were listed in the Safe 
Drinking Water Information System (SDWIS), but that only sold water to other systems, were 
also not mapped.  
When map revisions were complete, geocoded residential address were then linked 
spatially to a CWS service area. Geocoded addresses that were outside of the boundaries of a 
CWS were then excluded from the study. Residences were also linked to geographic data layers 
that provided the elevation at the residence (31), the census block group (to assign median 
income and median housing values in 1990 and 2000) (32), and the Rural-Urban Commuting 
Area Codes for 1900 and 2000 (33). Residences of mothers who gave birth before 1995 were 
assigned the values for 1990, and those who gave birth in 1995-2006 were assigned values for 
2000. 
The annual averaged arsenic value for the CWS providing drinking water to the 
residence during the first trimester of pregnancy (based on gestational age reported in vital 
records) was then linked to each woman.  
The arsenic concentration assigned to each woman was based on sample data in SDWIS 
reported by the CWS to the UDEQ during 1988 through 2007. While surface water systems are 





to report arsenic levels once every three years, unless arsenic levels from a prior year 
exceeded the MCL. In years where no sample result was reported or required, we used linear 
interpolation or extrapolation to assign the annual arsenic exposure estimate; for example, 
sample results reported in 1988 and 1991 were used to assign arsenic levels for 1989.  
Arsenic concentrations for each source were averaged for the year they were reported, 
and we then averaged the values from all sources for that year to assign the arsenic 
concentration for each CWS. Most of the 470 CWSs were operational throughout the study 
period, but many of the CWSs began operation in later years to provide service to a new 
subdivision, or became classified as a CWS due to an increase in the population of the service 
area (common in systems serving mobile home parks). Many of the CWSs merged with other 
CWSs or began purchasing some or all of their water from other CWSs during the study period. 
Many of the CWSs blend water from various sources that at times differed in arsenic value. We 
carefully reviewed the sample data and water sources before assigning annual arsenic exposure 
estimates for CWS. We did not have information on the proportion of water from each source, 
nor did we know which sources were used only seasonally. Arsenic values reported for wells 
identified as “inactive” were not included in the estimate during years the wells were inactive.  
Most samples reported as BD were assigned a value of half of the reported detection 
level. If the detection level was listed as zero, the value assigned was the higher value of 0.5 
or half of the detection level listed for other samples for that system during that year. Where 
detection limits were listed as 50 µg/L, we reviewed the other sample values for that source 
during the time period and, where the high detection limit seemed unreasonable, a more 
realistic value was assigned based on the other sample data from that system. Differing BD 
values within and between systems increased the risk of potential error in the arsenic 
estimates. To reduce the magnitude of error, we coded each sample value to identify samples 
that included BD values so that the data could later be modeled including and excluding 








The unit of analysis for this study is the individual mother. Bivariate analyses and 
multivariate logistic regression were used to assess the relationships between levels of arsenic 
in drinking water (and other covariates) with PRH. The measure of effect was the relative risk 
for PRH, adjusted for potential confounders and known risk factors. Statistical Analysis Systems 
software, version 9 (SAS, Cary NC) and Stata version 10 (Stata Corp., College Station, TX) were 
used for data reduction and statistical analyses.   
After examining distributions of PRH and the covariates and potential collinear 
relationships, we then assessed bivariate relationships. Covariates were identified as potential 
confounders if they were associated with both arsenic exposure and PRH at a significance level 
of p-value < 0.2 in bivariate analyses. Known risk factors for PRH included in the initial main 
effects models included maternal age, maternal weight gain, body mass index (BMI), smoking, 
alcohol use, multiple pregnancy, elevation, maternal race/ethnicity, chronic hypertension, 
parity, diabetes, renal disease, abruptio placenta, placenta previa, and socioeconomic status. 
Proxy measures for socioeconomic status were years of education, and the median income and 
median housing values for the mother‟s census block group (32).  
Elevation was categorized into 1,000 ft intervals ranging from <3,000 to >6,000. Arsenic 
concentration was assessed as a continuous variable and as a categorical variable. Sensitivity 
analyses were conducted to assess the effects of our assumptions in estimating annual average 
arsenic concentrations on the resulting associations with PRH. Finally, interaction terms were 
tested for all significant covariates that had the potential for effect modification.  
Stepwise procedures were followed by diagnostic tests such as likelihood ratio tests, to 
assess significance and goodness-of-fit after the addition of each covariate. The statistical 













Compared with those exposed to arsenic levels less than 2.5 µg/L, there was no 
increase in PRH with increasing levels of arsenic exposure; the aORs for the higher exposure 
categories ranged from 0.97 to 0.99. Only 150 of the maternal residences (0.02% of the study 
population) were in CWS service areas that had estimated arsenic levels greater than 40 µg/L; 
the highest exposure level was 126.1 µg/L. The covariates included in the final model are 
shown in Table 3.2. Because arsenic levels were interpolated for years when sampling was not 
required and/or reported to UDEQ, we reanalyzed the data excluding interpolated values, and 
then excluding all BD values. In each of the follow-up analyses, increased arsenic levels were 
not significantly associated with increased rates of PRH, and the aORs were essentially the 
same.  
 A majority of the residences (74%) were in CWSs with arsenic levels less than 2.5 µg/L, 
were located in urban areas (83%), and were at less than 5,000 ft elevation. Over 55% of the 
population had more than 12 years education, and over 38% of the mothers were age 18-24. 
The frequency of PRH was significantly increased at elevations greater than 6,000 feet 
(aOR 1.30, CI 1.10, 1.53), controlling for the covariates. PRH was increased at elevations 
between 5,000 to 6,000 feet, but the increase was not statistically significant.  
 Risk of PRH was significantly higher for women with higher BMI, with a threefold 
increase in women who were obese (aOR 3.11, CI 3.02, 3.20). Risks were also increased in 
women with diabetes (Type I or Type II, and gestational), in multiple pregnancies, in first 
pregnancies, and in women with comorbidities. PRH risk was increased in Native American 
women, and was decreased in Hispanic women.  
The mean arsenic levels for the entire study period, sources (surface or groundwater), 
and location (metropolitan or nonmetropolitan) for the 476 CWSs are shown in Table 3.3. 
During the study period, over 86% of the CWSs had an overall average arsenic concentration 
that was less than 5 µg/L; only 6% of the CWSs had an average arsenic concentration over 10 






Table 3.2 Covariates for PRH Study Included in Final Model, Utah, 1989-2006 
 Total # % #PRH   %PRH aOR 95% CI 
 
Arsenic in Drinking Water 
      
<2.5 µg/L (ref) 499,207 73.9% 26,121 5.2%   
2.5-5.0 µg/L  95,238 14.1% 4,800 5.0% 0.97 (0.93, 1.00) 
5.1-9.9 µg/L  56,444 8.4% 2,911 5.2% 0.98 (0.94, 1.02) 
>9.9 µg/L 24,941 3.7% 1,323 5.3% 0.99 (0.93, 1.05) 
Elevation at maternal residence       
<3,000 ft (ref) 3,994 0.6% 208 5.2%   
3,000-4,000 ft 5,445 0.8% 295 5.4% 0.95 (0.79, 1.15) 
4,000-5,000 ft 592,930 87.8% 30,228 5.1% 0.89 (0.77, 1.03) 
5,000-6,000 ft 61,965 9.2% 3,682 5.9% 1.09 (0.94, 1.27) 
>6,000 ft 11,378 1.7% 739 6.5% 1.30 (1.10, 1.53) 
Maternal age       
18-19 41,480 6.1% 2,276 5.5% 0.93 (0.89, 0.98) 
20-24 216,131 32.0% 12,102 5.6% 1.03 (1.00, 1.06) 
25-29 (ref) 222,646 32.9% 10,951 4.9%   
30-34 132,951 19.7% 6,183 4.7% 1.00 (0.96, 1.03) 
>34 62,609 9.3% 3,641 5.8% 1.21 (1.16, 1.26) 
Maternal Race       
Black 4,652 0.7% 219 4.7% 0.82 (0.71, 0.96) 
Native American 7,499 1.1% 537 7.2% 1.10 (1.00, 1.21) 
White (ref) 639,057 95.1% 33,422 5.2%   
Other races 20,676 3.1% 782 3.8% 0.66 (0.61, 0.71) 
Hispanic       
Yes 72,416 10.7% 3,329 4.6% 0.82 (0.71, 0.96) 
No (ref) 601,557 89.3% 31,737 5.3%   
Pre-pregnancy BMI       
Lowest 43,692 7.1% 1,090 2.5% 0.72 (0.68, 0.77) 
Normal 374,801 60.7% 14,233 3.8%   
Overweight 119,783 19.4% 8,352 7.0% 1.74 (1.69, 1.79) 
Obese 79,178 12.8% 8,736 11.0% 3.11 (3.02, 3.20) 
Multiple pregnancy       
Yes 18,041 2.7% 2,081 11.5% 2.44 (2.32, 2.57) 
No (ref) 657,702 97.3% 33,071 5.0%   
Type I or Type II diabetes       
Yes 2,056 0.3% 357 17.4% 2.74 (2.42, 3.10) 
No (ref) 673,774 99.7% 34,798 5.2%   
Gestational diabetes       
Yes 10,202 1.5% 1,228 12.0% 1.94 (1.82, 2.07) 
No (ref) 665,628 98.5% 33,927 5.1%   
Smoking during pregnancy       
Yes 53,500 7.9% 2,204 4.1% 0.80 (0.76, 0.84) 
No (ref) 622,208 92.1% 32,944 5.3%   
Abruptio placenta       
Yes 7,984 1.2% 581 7.3% 1.57 (1.43, 1.72) 
No (ref) 667,846 98.8% 34,574 5.2%   
Weight gain for BMI       
Recommended 266,235 39.4% 9,977 3.8%   
Low gain 159,758 23.6% 5,929 3.7% 0.89 (0.86, 0.92) 
High gain 249,837 37.0% 19,249 7.7% 1.70 (1.65, 1.74) 
Anemia (maternal)       
Yes 17,914 2.7% 1,192 6.7% 1.32 (1.24, 1.41) 





Table 3.2 continued 
 Total # % #PRH   %PRH aOR 95% CI 
       
Renal disease (maternal)       
Yes 9,037 1.3% 885 9.8% 1.84 (1.71, 1.98) 
No (ref) 666,793 98.7% 34,270 5.1%   
First pregnancy       
Yes 195,345 29.1% 15,002 7.7% 2.19 (2.14, 2.25) 
No (ref) 476,198 70.9% 19,980 4.2%   
Cardiac disease (maternal)       
Yes 4,876 0.7% 404 8.3% 1.49 (1.33, 1.66) 
No (ref) 670,954 99.3% 34,751 5.2%   
Respiratory disease (maternal)       
Yes 12,290 1.8% 1,103 9.0% 1.45 (1.35, 1.55) 




Table 3.3 Overall Mean Arsenic Concentrations (1989-2006) by Community Water System 




































2.5-5 116 24% 16 18% 100 26% 21 18% 95 27% 
5.1-9.9 43 9% 4 4% 39 10% 8 7% 35 10% 
>9.9 27 6% 2 2% 25 6% 5 4% 22 6% 









Over 80% of the CWSs relied primarily on groundwater; 7% of the groundwater systems 
had average arsenic levels of 10 µg/L or greater, compared with 2% of the systems supplied 
primarily by surface water. Only 25% of the water systems served metropolitan areas, and they 





 After adjusting for multiple potential confounders and known risk factors for PRH, we 
found no association between arsenic exposure and increased risk of PRH. The large sample 
size and substantial gradient of arsenic exposure levels provides good power to detect 
differences in PRH risk. As such, there is good evidence that arsenic exposures at these levels 
do not increase the risk of PRH. 
 These results are not consistent with the findings of the Tabacova studies in Bulgaria 
(16, 17) that found an association with preeclampsia and arsenic (and other metals), nor is it 
consistent with the studies conducted in China, Taiwan, and Bangladesh that found associations 
between arsenic in drinking water and hypertension (11-14). In the hypertension studies, 
however, the effects from arsenic exposure were seen at levels from 20-100 µg/L (11-14). 
Arsenic exposure levels were much lower in our study; the median level for the highest 
exposure group was 14.8 µg/L. The Tabacova studies in Bulgaria investigated arsenic exposures 
primarily through air near a copper smelter; the report also did not present additional 
information on other factors or exposures that could be associated with rate differences (15).   
We also found a strong relationship between elevation greater than 6,000 feet and the 
risk of PRH, which is consistent with findings from Tibet, Bolivia, and Colorado (34-38). While 
PRH was increased, though not significantly, at elevations from 5,000 to 6,000 feet, there was 
no increase in PRH at elevations from 3,000 to 5,000 feet compared with lower elevation. 
Elevation exposure assignment was based on residential address, providing an increased level 
of accuracy in comparison to studies where elevation was based on county or census block 





chronic hypoxia; however, the mechanisms by which hypoxia acts to reduce fetal growth are  
not well understood (36-38).  
Observed associations with known risk factors were as expected; PRH was significantly 
more common with obesity, excess weight gain, and nulliparity, and was less common with 
maternal smoking (39).    
A major limitation of the study is lack of individual level data on water consumption,  
as this study relied on vital records data. Our method assumes uniform water consumption 
rates across individuals and over time, and that women who resided in an area served by a  
CWS drank tap water (not filtered by reverse osmosis) from that system.   
CWSs differed in the number of samples and number of years of sample collection; 
however, reported arsenic levels within each CWS were generally consistent throughout the 
study period. The use of BD values was also problematic, as they varied between and within 
years for different systems, with reported detection limits ranging from 0 to 50 µg/L. These 
factors may lead to exposure errors which cannot be quantified. Our sensitivity analyses, 
however, showed very little change in results using more stringent assumptions. The overall 
general consistency in arsenic levels within systems also reduces the impact of these potential 
errors.  
An additional limitation is that arsenic levels from all sources within a system were 
averaged to determine an annual arsenic level for each CWS. Factoring in the timing and 
quantity of water from each source would provide a much more accurate arsenic estimate. 
Review of individual water system records beyond that available in the SDWIS database, 
however, was beyond the scope of this study. 
We also did not know in the length of time during the pregnancy (or earlier) that a 
woman lived at the residence within the CWS service area providing service at the time of 
delivery. Residential mobility during pregnancy has been reported in other studies to range 
from 20 to 30%. (40-44). Although most relocations have been found to be within the same 





This study included women who were pregnant more than once during the study 
period. While some women lived in one residence (and one CWS) for all pregnancies, other 
women may have moved several times, and may or may not have been exposed to differing 
levels of arsenic during each pregnancy. As risk may increase with an increased number of 
years of chronic arsenic exposure, additional studies are recommended that assess residential 
mobility in terms of CWS exposure levels.   
Many CWS boundaries change, sometimes greatly, over time to accommodate growing 
community needs for drinking water. Errors in the exact boundaries of the CWS service areas, 
and incorrectly geocoded maternal residences, would also affect the results. The large sample 
size, and efforts to validate CWS boundaries during the study time period and individual 
residential locations, likely minimized any systematic errors that would result from these 
inaccuracies. 
There is some limitation in generalizability of these results due to differences in the 
racial distribution in Utah as compared to the US population, with 95.1% White in Utah 
(compared with 75.1% US), 0.7% Black (compared with 12.3% US), and 10.8% Hispanic 
(compared with 12.5% US) (32). 
There were large potential differences in behavioral risk factors as well, as smoking 
and alcohol use are proscribed by the predominant religion in Utah. For example, less than 8% 
of the women in this study reported smoking, compared with the 23% national estimate in 2000 
(45). In spite of these differences, the estimated effects of risk factors (other than arsenic) 
were comparable to results from other studies.   
This study, however, included all eligible births over a 17-year period, CWS service 
areas were carefully researched, and the assignment of maternal address to CWS was based on 
geocoding of actual street address. We, thus, expect there to be little error in linking arsenic 
levels to individuals. In addition, most of the major known risk factors were included in the 
analysis. This adds credibility to the finding of no statistically significant association of PRH 






This study only assessed exposure to arsenic levels common in populations where 
drinking water is supplied by a CWS. Women who lived outside of areas served by a CWS were 
not included in the analysis. In many areas of Utah, groundwater levels are among the highest 
in the US (4). Additional studies are recommended in these areas to investigate whether PRH is 
increased at high arsenic exposure levels, and to provide a basis for actions to reduce risk 
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 Chronic exposure to high levels of arsenic in drinking water has been associated with a 
number of adverse reproductive outcomes, including stillbirth, spontaneous abortion, and 
lower birth weight. Most studies of exposure to arsenic have been in areas such as Bangladesh 
or Taiwan where arsenic levels in drinking water were extremely elevated. Very few studies 
have investigated health effects from exposure to levels of arsenic common in Community 
Water Systems (CWSs) in the United States. Maternal addresses at time of delivery were 
geocoded for over 650,000 births and stillbirths in Utah during 1989–2006. Annual average 
arsenic levels were estimated for 476 Utah CWSs using monitoring data submitted to the Utah 
Department of Environmental Quality. Annual arsenic levels for each CWS were assigned to 
each birth and stillbirth based on conception year by linking geocoded addresses to 
georeferenced service areas for each CWS. Multiple births and infants with birth defects were 
excluded from the study. The level of arsenic was not associated with incidence of stillbirth in 
a model that adjusted for maternal age, diabetes, birth weight, preterm birth, weight gain, 
and other risk factors. Compared with women whose tap water arsenic concentrations were 
less than 2.5 micrograms per liter (µg/L), the adjusted odds ratio (aOR) for those with 2.5–5 
µg/L was 1.15, 95% confidence interval (CI): 1.00, 1.31; for those with 5–10 µg/L, aOR 0.77,  










Chronic exposure to high levels of arsenic in drinking water has long been linked to a 
number of cancers and diseases (1-5), particularly in areas such as Bangladesh and Taiwan 
where arsenic levels are extremely high. Evidence linking exposure to arsenic in drinking water 
with adverse birth outcomes has been less consistent. Stillbirth, for example, was found to be 
associated with increased arsenic exposure in drinking water in studies in Chile, Bangladesh, 
India, and Hungary (6-12), while studies in China, Bangladesh and Massachusetts found no 
association between stillbirth and arsenic exposure (13-16). 
Arsenic is released into the environment through natural processes of erosion, leaching, 
and wind-blown soil (1, 17). Pesticide application, mining activities, waste incineration, and 
combustion of wood or coal are other major sources of arsenic releases to air, water, and soil. 
In Utah, weathering of volcanic rocks and erosion of slag and soil from past mining activities 
are the major sources of arsenic in groundwater (18, 19). Arsenic levels in groundwater arsenic 
levels vary greatly across the US, and across Utah as well; arsenic levels in drinking water in 
Utah range from below the limit of detection (BD) to over 400 micrograms per liter (µg/L) in 
some private wells (20, 21).  
There is no universally accepted definition for stillbirth (22). In the US, stillbirth 
usually refers to a fetal death after 20 weeks gestation; pregnancy loss before 20 weeks is 
defined as a spontaneous abortion. In Utah, fetal death certificates are required for fetal 
deaths at 20 or more weeks of gestation (23). The incidence of stillbirth in Utah is 
approximately 4.9 per 1,000 live births.  
Although many studies of the effects of arsenic have been conducted in vivo, and in 
vitro, the exact biologic mechanisms underlying the effects of arsenic are unknown (24). 
Inorganic arsenic readily crosses the placental barrier (1, 25). Vascular endothelial cells are 
suspected to be primary targets of arsenic toxicity (26). Mechanical and chemical injury of the 
vascular endothelium triggers a cascade of processes that individually and jointly can result in 
adverse outcomes. Arsenic exposure has also been found to cause defective placental 





subsequent spontaneous abortion (27). Arsenic has also been found to increase oxidative stress, 
which is seen in pregnancies complicated by preeclampsia and intrauterine growth restriction 
(28), which are both risk factors for stillbirth (29).  
The purpose of this study was to investigate whether there is an association between 





Study Design and Study Population 
 This is a retrospective cohort study of stillbirth occurrence in Utah residents during 
January 1, 1989, to December 31, 2006. For this study “stillbirth” is defined as 1) pregnancy  
loss at 20 weeks gestation or later in Utah recorded on a fetal death certificate, and 2) 
pregnancy loss where a birth certificate was issued but the 1-minute and 5-minute Apgar scores 
were both zero.  
Fetal death and birth certificate data were obtained from the Utah Department of 
Health (UDOH) Office of Vital Records and Statistics. Maternal addresses were provided 
electronically for births; maternal addresses for stillbirths were transcribed directly from fetal 
death certificates by the research team. 
 Utah residents ages 18 and older, and whose residential addresses as listed on birth or 
fetal death certificates were within the boundaries of a CWS, were included in the study. (See 
Table 4.1 for maternal demographic data.) A CWS is a water system that provides drinking  
water to at least 15 residential service connections or at least 25 people year-round, and as 
such, is regulated under the Safe Drinking Water Act and required to conduct regular  
monitoring of water quality (30). 
Multiple births, infants with birth defects, and fetal deaths identified in vital records  
as being due to trauma, maternal death, infection, or breech delivery were excluded.  
Other exclusions included births and stillbirths: a) outside of Utah to Utah residents; b) with  
no address reported on the birth or fetal death certificate; c) where address information was 





Table 4.1 Maternal Demographics for Stillbirth Study, Utah, 1989-2006 
 Total # % # Stillbirths % 
 
Age 
    
18-19 39,701 6.2% 144 0.36% 
20-24 205,891 32.2% 645 0.31% 
25-29 210, 879 33.0% 712 0.34% 
30-34 125,045 19.5% 533 0.43% 
>34 58,398 9.1% 415 0.71% 
Race     
Black 4,306 0.7% 30  0.70% 
Native American 7,128 1.1% 38 0.53% 
White 605,032 93.7% 2,285 0.38% 
Other races 19,712 3.1% 86 0.44% 
Hispanic     
Yes 68,873 10.8% 335 0.49% 
No 569,294 89.2% 2,124 0.37% 
Education     
<12 years 75,733 12.0% 1,206 1.59% 
12 years 207,307 32.8% 425 0.21% 
>12 years 348,812 55.2% 683 0.20% 
Marital status     
Married 546,080 85.3% 1,974 0.36% 
Unmarried 93,822 14.7% 465 0.50% 
Smoking during pregnancy     
Yes 50,743 7.9% 235 0.46% 
No 589,101 92.1%            2,144   0.36% 
Alcohol during pregnancy     
Yes 8,642 1.4% 36 0.42% 
No 627,371 98.6% 1,893 0.30% 
First pregnancy     
Yes 187,140 29.4% 752 0.40% 
No 448,827 70.6% 1,588 0.35% 
Type I or Type II diabetes     
Yes 1,843 0.3% 40 2.17% 
No 638,081 99.7% 2,419 0.38% 
Gestational diabetes     
Yes 9,470 1.5% 32 0.34% 
No 630,454 98.5% 2,427 0.38% 
Pre-pregnancy BMI     
Lowest 41,479 7.1% 132 0.32% 
Normal 355,650 60.8% 1,177 0.33% 
Overweight 113,285 19.4% 475 0.42% 
Obese 74,396 12.7% 409 0.55% 
Weight gain for BMI     
Recommended 254,858 39.8% 494 0.19% 
Low gain 151,796 23.7% 1,589 1.05% 
High gain 233,270 36.5% 376 0.16% 
Rural/Urban Commuting Area     
Metropolitan 529,096 82.2% 2,021 0.38% 
Metropolitan adjacent 43,003 7.7% 188 0.44% 
Small town 40,293 6.1% 149 0.37% 






CWS; d) that occurred in 1990 because addresses were not available on the electronic birth 
files for that year; and e) where the address was within a tribal CWS and water quality 
information was not available.  
Of the 3,943 stillbirths, 725 stillbirths in Utah to women age 18 or older in 1989-2006, 
1,484 (37.6%) were excluded from the study; 87,549 (12.1%) of the 725,014 live births were 
excluded. This left a final sample size of 639,924, including 637,465 live births and 2,459 fetal 
deaths, of which 119 were identified on the basis of the 1-minute and 5-minute Apgar scores 





 Water quality data from the Safe Drinking Water Information System (SDWIS), that 
included 27,500 arsenic sample results for years 1978-2007, was provided by the Utah 
Department of Environmental Quality (UDEQ) for all water systems. We used these data to 
estimate annual average arsenic concentrations for each CWS. When there was no sample 
result reported for a given year, we used linear interpolation or extrapolation to estimate 
arsenic values.  
 Some CWSs had consistent water sources for the entire time period, while others 
merged with other systems or began purchasing water from other CWSs, particularly in later 
years, to improve water quality or to consolidate regionally to provide more efficient service. 
CWSs commonly blend water from various sources that may have different arsenic levels. 
Where a CWS had two or more water sources, we first averaged the arsenic values reported 
that year for each source, and then averaged the arsenic values for all sources.  
Water volumes from different sources are often not equal, and some sources are used 
only seasonally; however, data on water volume and number of days annually that each source 
was used were not available for this study. As a result, all sources within a CWS were assumed 
to have contributed equally. 
Where a sample value was reported as BD, we generally assigned the sample a value of 































Excluded - 25,985 not geocoded 
 12,134 geocoded but not in CWS 
     14,797 geocoded but no arsenic data 
Live births in Utah to Utah residents 
age 18 or older = 725,014 
672,098 live births Geocoded and 
within community water system 
boundaries 
Excluded - 17,680 Multiple births 
      16,953 Infants with birth defects 
637,465 live births included in study 
Stillbirths in Utah to Utah residents 
ages 18 or older = 3943 
Excluded – 53 not geocoded 
                 71 geocoded not in water system 
                 87 geocoded but no arsenic data 
3,732 Stillbirths geocoded and 
within community water system 
boundaries 
Excluded – 361 Multiple births 
                 823 Infants with birth defects 
  89 Infants with trauma, infection, 
maternal death, or breech 
delivery listed as cause of death 
2,459 Stillbirths included in study 
639,924 live births and stillbirths 
included in study 
Figure 4.1 Stillbirth Study – Exclusion and Inclusion Criteria for Live Births and Fetal 





added to the estimate for that water source, particularly since the reported detection levels 
were not consistent between CWSs within a year, nor were they consistent over time due to 
changes in technology and the use of different laboratories. To address these inconsistencies, 
annual sample values for each CWS were coded to identify samples that included BD values, 
and sensitivity analyses were carried out.  
Maternal addresses from the birth and fetal death certificates were geocoded using 
ArcGIS® 9.3 (ESRI, Redlands, CA). Only 1% of the maternal addresses for the stillbirths were  
not geocoded, and these were due to missing address data. Over 97% of the maternal  
addresses for the live births in each county were geocoded with sufficient precision to 
determine their CWS, or that they were outside of the boundaries of a CWS.  
The Utah Department of Natural Resources (UDNR) provided a spatial database of CWS 
service area boundaries. Using publicly available information and records from the UDEQ and 
Utah Automated Geographic Reference Center, CWS boundaries were updated, and 53 CWSs 
were added to the database. The geocoded addresses were then linked to the CWS spatial 
database. Maternal addresses were also linked to census block group (for median income and 
median housing value information) (31) and to Rural-Urban Area Code boundaries (32).  
Finally, each birth and stillbirth was linked to the annual estimated arsenic 
concentration for the CWS that provided service at the maternal residence during first 






The individual births and stillbirths are the units of analysis for this study. Bivariate 
analyses and multivariate logistic regression were used to assess the relationship between 
differing levels of arsenic in drinking water and stillbirth, and to assess the degree of 
correlation between covariates. Covariates were identified as potential confounders if they 
were associated with both arsenic exposure and stillbirth at a significance level of p-value  





confounders, was the measure of effect. Stata version 10 (College Station, TX) and Statistical 
Analysis Systems (SAS) software, version 9 (Cary NC), were used for data processing and 
statistical analyses.   
Potential confounders and known risk factors for stillbirth in the initial main effects 
models included preterm birth, low birth weight, smoking, alcohol use, diabetes, maternal 
race/ethnicity, parity, chronic hypertension, pregnancy-related hypertension, renal disease, 
abruptio placenta, cord prolapse, placenta previa, anemia, and socioeconomic status. Median 
family income and median housing values (based on census block group) (31), and education 
were used as proxy measures for socioeconomic status.  
Arsenic concentration was assessed as a continuous variable and as a categorical 
variable. Sensitivity analyses were conducted to assess the effects of our assumptions in 
estimating annual average concentrations on the resulting associations with stillbirth. 
Interaction terms were tested for all covariates that previous studies or etiology suggested had 
the potential for effect modification. Stepwise procedures, followed by likelihood ratio tests, 
were used to assess significance and goodness-of-fit after the addition of each covariate. Two-
sided tests with an alpha of 0.05 were used to assess statistical significance. 
The Institutional Review Boards from the University of Utah (Project #00023217) and 





Compared with arsenic levels less than 2.5 µg/L, there was no increase in stillbirth  
with increasing levels of arsenic exposure (Table 4.2). The aOR was less than 1 for arsenic 
levels > 5.0 µg/L, but there was no consistent trend. The continuous arsenic concentration 
measure was likewise nonsignificant with an odds ratio near one (aOR 0.99; 95% CI 0.97, 1.00). 
Arsenic levels were less than 2.5 µg/L for the majority of the residences (73.8%). The median 
exposure level in the highest arsenic category was 11.7 µg/L (mean 13.0 µg/L). Only 144 of the 
women (0.02% of the study population) lived in CWS service areas that had estimated arsenic 





Table 4.2 Covariates Included in Final Model for Stillbirth Study, Utah, 1989-2006 
 Total # % #Stillbirths   %    aOR     95% CI 
 
Arsenic in Drinking Water 
      
<2.5 µg/L (ref) 472,521 73.8% 1,821 0.39%   
2.5-5.0 µg/L  90,341 14.1% 342 0.38% 1.12 (0.96, 1.30) 
5.1-9.9 µg/L  53,435 8.4% 200 0.37% 0.73 (0.60, 0.88) 
>9.9 µg/L 23,627 3.7% 96 0.41% 0.82 (0.63, 1.07) 
Maternal age       
18-19 39,701 6.2% 144 0.36% 0.34 (0.27, 0.42) 
20-24 205,891 32.2% 645 0.31% 0.65 (0.57, 0.74) 
25-29 (ref) 210,879 33.0% 712 0.34%   
30-34 125,045 19.5% 533 0.43% 1.16 (1.00, 1.34) 
>34 58,398 9.1% 415 0.71% 1.58 (1.34, 1.85) 
Education       
<12 years 75,733 12.0% 1,206 1.59%     7.46 (6.52, 8.55) 
12 years (ref) 207,307 32.8% 425 0.21%   
>12 years 348,812 55.2% 683 0.20%      0.99 (0.85, 1.14) 
Pre-pregnancy BMI       
Lowest 41,479 7.1% 132 0.32% 0.57  (0.46, 0.70) 
Normal 355,650 60.8% 1,177 0.33%   
Overweight 113,285 19.4% 475 0.42% 1.29  (1.13, 1.47) 
Obese 74,396 12.7% 409 0.55% 1.24  (1.07, 1.42) 
Weight gain for BMI       
Recommended 254,858 39.8% 494 0.19%   
Low gain 151,796 23.7% 1,589 1.05% 2.00  (1.77, 2.27) 
High gain 233,270 36.5% 376 0.16% 0.95  (0.82, 1.11) 
Birth weight       
Low birth weight 26,414 4.1% 389 1.47% 5.49  (4.60, 6.56) 
Very low birth weight  5,326 0.8% 1,215 22.81% 67.7  (56.2, 81.5) 
Not low birth weight (ref) 607,694 95.0% 646 0.11%   
Preterm       
Yes 48,370 7.6% 1,742 3.60% 2.84  (2.40, 3.37) 
No (ref) 591,554 92.4% 717 0.12%   
Anemia (maternal)       
Yes 16,488 2.6% 402 2.44% 6.78 (5.84, 7.88) 
No (ref) 623,436 97.4% 2,057 0.33%   
Type I or Type II diabetes       
Yes 1,843 0.3% 40 2.17% 1.84  (1.15, 2.96) 
No (ref) 638,081 99.7% 2,419 0.38%   
Abruptio placenta       
Yes 7,186 1.1% 314 4.37% 1.46 (1.23, 1.73) 
No (ref) 632,738 98.9% 2,145 0.34%   
Cord prolapse       
  Yes 1,571 0.3% 41 2.61% 2.32 (1.47, 3.66) 









As arsenic levels were interpolated for years when sampling was not required and/or 
was not reported to UDEQ, we repeated the analyses first excluding interpolated values, and 
then excluding all BD values. In each of the follow-up analyses, increased arsenic levels were 
not significantly associated with increased rates of stillbirth, and the aORs were essentially the 
same. See Table 4.2 for the covariates included in the final model.  
Observed associations between known risk factors and stillbirth were statistically 
significant. Risk of stillbirth was highest in very low birth weight pregnancies (aOR 67.7, CI 
56.2, 81.5); in women with less than 12 years education (aOR 7.46, CI 6.52, 8.55); and in 
women with anemia, (aOR 6.78, CI 5.84, 7.88). Risks for stillbirth were also increased in 
women over age 34, in preterm births, in women who gained less weight than recommended 
for their body mass index (BMI), in women with Type I or Type II diabetes (but not gestational 
diabetes), and in women with pregnancy complications. 
In the bivariate analyses, stillbirth risk was increased in Black women (aOR 1.85, CI 
1.29, 2.66); in Native American women (aOR 1.41, CI 1.03, 1.95); and in Hispanic women (aOR 
1.31, CI 1.16, 1.47). Race and ethnicity, however, were highly correlated with low birth weight 
and education, leading to unstable estimates in the logistic regression; as such, they were not 





 After adjusting for multiple potential confounders and known risk factors for stillbirth, 
we found no association between arsenic exposure and increased risk of stillbirth. Studies to 
date on whether stillbirth is associated with arsenic exposure in drinking water have had mixed 
results (6-16). Studies with positive findings were in areas with very high arsenic levels, with 
arsenic reference levels ranging from 50 to 200 µg/L of arsenic. Our study examined effects at 
much lower levels; the median level for the highest exposure group was 11.7 µg/L (mean 13.0 
µg/L), and the reference level for arsenic was 2.5 µg/L.  
While it is possible that exposures to these moderate levels may result in only modest 





stillbirths in Utah over a 17-year period, and completeness of address geocoding in this study 
provide evidence that any excess risk would be quite small. Exposure assignment, however, 
was limited by the lack of individual level data on water consumption. The exposure metric 
does not reflect the variability in exposure due to differences in the amount of home tap water 
consumed, exposure from drinking water at work or at other locations, or the effects of home 
treatment using reverse osmosis. 
The number of samples and number of years of sample collection and reporting varied 
in the 476 CWSs; some systems reported arsenic sample results every year of the study time 
period, while some systems were only operational for one to three years of the time period. 
The BD values also varied by system and over time, which may lead to exposure errors; our 
sensitivity analyses, however, showed very little change in results. Averaging arsenic levels 
from all sources to determine an annual average arsenic level, without factoring in when each 
source was being used and how much it produced, also affected the precision and accuracy of 
the exposure estimates. Review of individual CWS records beyond that available in the SDWIS 
database, however, was beyond the scope of the study.  
We also did not know whether the address recorded on vital records at the time of 
delivery was where the mother lived during the critical early months of the pregnancy. 
Residential mobility during pregnancy has been reported in other studies to range from 20 to 
30% (33-37). While most moves have been found to be within the same general community, in 
some cases moving even a very short distance could result in being served by a different CWS 
that may have higher or lower arsenic levels. In addition, many of the women in the study had 
more than one pregnancy during the study time period, and may have lived in several different 
CWS services areas with varying levels of arsenic exposure during these pregnancies. A study by 
Ahmad in Bangladesh found that women exposed to high levels of arsenic in drinking water for 
greater than 15 years had a stillbirth rate of 77.5 per 1,000, while the rate in those exposed for 
less than 15 years was 43.5 per 1,000 (10). As risks may increase with length of time of 
exposure to higher levels of arsenic, additional studies are recommended to better identify 





There is some limitation in generalizability due to differences in the racial and religious 
breakdown of the Utah population. Utah is predominantly White (95.1% compared with 75.1% 
US), with only 0.7% Black (compared with 12.3% US) and 10.8% Hispanic (compared with 12.3% 
US) (31). Another major difference is that over half of the Utah population members of The 
Church of Jesus Christ of Latter Day Saints who follow religious proscriptions against tobacco 
and alcohol consumption. Less than 8% of the women in our study reported smoking, compared 
with the 23% national estimate for 2000 (38). 
This study included all eligible births over a 17-year period. CWS service areas were 
carefully researched, and the assignment of maternal address to CWS was based on geocoding 
of actual street address. As a result, we expect there to be little error in linking arsenic levels 
to individuals. Further, most of the major known risk factors were included in the analysis. This 
adds credibility to the finding of no statistically significant association of stillbirths with arsenic 
levels in drinking water within the range of average annual sample value for the CWSs in this 
study.  
This study assessed exposures to arsenic concentrations common in US populations that 
whose drinking water is supplied by a CWS. Women whose drinking water was supplied by 
private wells were not included in the analysis. In a few areas of Utah, groundwater arsenic 
levels are some of the highest in the US (20, 21). Additional studies are recommended in areas 
where private wells have high arsenic levels to better assess the relationship of stillbirth at 
high arsenic levels, and to provide a basis to determine whether additional actions are 
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 The purpose of this research was to investigate whether exposure to low to moderate 
levels of arsenic in drinking water in community water systems (CWSs) in Utah in 1989-2006 are 
associated with elevated levels of small for gestational age (SGA) birth, pregnancy-related 
hypertension (PRH), and/or stillbirth. Results of the study are summarized below.  
 
 
Small for Gestational Age 
 
While studies have looked at the effect of arsenic on lower birth weight (1-3), no 
studies to date, to my knowledge, have looked at whether SGA at individual weeks 22-44 is 
associated with arsenic exposure. In this study there was a small, but statistically significant 
increase in the risk of SGA with increasing levels of arsenic in drinking water; compared with 
arsenic levels less than 2.5 µg/L, the adjusted odds ratio (aOR) for arsenic levels at 5.1 to 9.9 
µg/L in drinking water was 1.04, 95% confidence interval (CI) 1.00, 1.07 for SGA; and at levels 
10 µg/L and above the aOR was 1.07 (CI 1.03, 1.12). The sample size for the analysis, after 
excluding multiple births, infants with birth defects, stillbirths, nonresidents, maternal 
addresses outside of CWS boundaries, and those with missing data on gestational age, birth 
weight, and maternal address, was 631,375 births.    
The SGA study also yielded a finding that the risk of SGA increased significantly with 
each 1,000 feet increase in elevation. Compared with births at elevations less than 3,000 ft, 
the aOR for SGA increased with every 1,000 ft gain in elevation, to an aOR of 1.90 (CI 1.64, 








There was no statistically significant association found between exposure to elevated 
levels of arsenic in drinking water and pregnancy-related hypertension. Compared with tap 
water arsenic concentrations less than 2.5 µg/L, the aOR for those exposed to 2.5–5 µg/L was 
0.97 (CI 0.93, 1.00); for those exposed to 5–10 µg/L, aOR 0.98 (CI 0.94, 1.02); and for those 
exposed to levels at or above 10 µg/L, aOR 0.99 (CI 0.93, 1.05). 
Two studies in Bulgaria found increased risk of pregnancy related hypertension in 
women exposed to arsenic and other metals (4, 5); however, the exposure pathways 
investigated were air and soil and not drinking water. Only one other study investigated 
whether hypertension during pregnancy is associated with arsenic exposure (6); in that study, 
however, the investigators only assessed blood pressure during pregnancy, and did not 
investigate whether preeclampsia or eclampsia were elevated with increased arsenic exposure.  
After excluding nonresident births and maternal addresses that were outside of CWS 
boundaries or that had inadequate address information recorded on vital records, the final 





No statistically significant association was found between exposure to elevated levels 
of arsenic in drinking water at the levels found in Utah community water systems and stillbirth. 
Compared with women whose tap water arsenic concentrations were less than 2.5 µg/L, the 
aOR for those exposed to 2.5–5 µg/L was 1.15 (CI 1.00, 1.31); for those exposed to 5–10 µg/L, 
aOR 0.77 (CI 0.65, 0.91); and for those exposed to levels at or above 10 µg/L, aOR 0.88 (CI 
0.70, 1.10). 
Several studies have investigated whether stillbirth is associated with high 
concentrations of arsenic in drinking water, with mixed findings (3-6). These studies, however, 
were in areas with very high arsenic levels in drinking water. Arsenic reference levels in these 





After excluding multiple births; birth defects; fetal deaths due to trauma, maternal 
death, infection, or breech delivery; nonresident births and stillbirths; maternal residence 
outside of a CWS; and inadequate address information, the final sample size was 639,924, 





 These studies help to clarify the risks posed by low to moderate levels of arsenic on 
adverse birth outcomes. The large sample sizes and the use of almost all births among Utah 
residents over a 17-year period that were served by CWSs minimizes selection bias and provides 
adequate power to detect even small increases in risk, should they exist. While small, yet 
statistically significant increases in the risk of SGA births were observed, no such effects were 
seen for stillbirth or pregnancy-related hypertension. 
 One of the limitations of using a large population-based dataset is the lack of 
individual information about water use behaviors, which leads to errors in the estimates of 
exposure. Such errors may bias effect measures toward the null. A large sample size is needed, 
however, to have sufficient statistical power to assess the effects of low levels of arsenic in 
drinking water, particularly since there are many known risk factors for these outcomes. Future 
studies are recommended that account for individual variability in water consumption and 
household treatment, but the required sample size may be prohibitively expensive. 
The study findings described in detail in Chapters 2-5 apply to arsenic exposure levels 
in drinking water that are low to moderate. The effects of arsenic were assessed in four 
categories of exposure – less than 2.5 µg/L (reference group), 2.5-5 µg/L, 5.1-9.9 µg/L, and 10 
µg/L or greater. Only 3.7% of the population were exposed to estimated arsenic levels of 10 
µg/L or greater. The median annual arsenic level in this category was only 11.7 µg/L, and less 
than 0.02% of the population were exposed to arsenic levels greater than 40 µg/L. Several 
studies have found an association between high levels of arsenic in drinking water and 





association between high levels of arsenic exposure in drinking water and increased rates of 
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